Herbas VPB

Print
EN | LT
LT - 2-Heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidai, skirti vėžio gydymui
EN - 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/14 (2006.01)
C07D 405/14 (2006.01)
C07D 401/04 (2006.01)
C07D 403/04 (2006.01)
C07D 237/04 (2006.01)
C07D 237/24 (2006.01)
C07D 409/04 (2006.01)
C07D 413/04 (2006.01)
C07D 417/04 (2006.01)
C07D 417/14 (2006.01)
A61K 31/501 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3580211
(13) Kind of document T
(96) European patent application number 18703958.1
Date of filing the European patent application 2018-02-02
(97) Date of publication of the European application 2019-12-18
(45) Date of publication and mention of the grant of the patent 2020-12-02
(46) Date of publication of the claims translation 2021-02-25
PCT application
(86) Number PCT/EP2018/052627
Date 2018-02-02
PCT application publication
(87) Number WO 2018/146010
Date 2018-08-16
Priority applications
(30) Number Date Country code
17155406 2017-02-09 EP
17202882 2017-11-21 EP
Inventors
(72)
GUTCHER, Ilona, DE
RÖHN, Ulrike, DE
SCHMEES, Norbert, DE
ZORN, Ludwig, DE
RÖSE, Lars, DE
BADER, Benjamin, DE
KOBER, Christina, DE
CARRETERO, Rafael, DE
STÖCKIGT, Detlef, DE
IRLBACHER, Horst, DE
PLATTEN, Michael, DE
Grantee
(73) Bayer Pharma Aktiengesellschaft, Müllerstrasse 178, 13353 Berlin, DE
Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg, DE
Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) 2-Heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidai, skirti vėžio gydymui
  2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER
Last renewal fee
Payment date Validity (years) Amount
2024-01-19 7 162.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2025-02-02